DYN
Price
$18.52
Change
+$0.31 (+1.70%)
Updated
Sep 14 closing price
Capitalization
3.46B
44 days until earnings call
Intraday BUY SELL Signals
XFOR
Price
$3.62
Change
+$0.12 (+3.43%)
Updated
Sep 14 closing price
Capitalization
358.91M
44 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

DYN vs XFOR

DYN vs XFOR Comparison Chart in %
View a ticker or compare two or three
VS
DYN vs. XFOR commentary
Sep 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DYN is a Hold and XFOR is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DYN($3.46B) has a higher market cap than XFOR($359M). DYN YTD gains are higher at: -5.317 vs. XFOR (-9.500). XFOR has higher annual earnings (EBITDA): -79.76M vs. DYN (-502.36M). DYN has more cash in the bank: 898M vs. XFOR (208M). XFOR has less debt than DYN: XFOR (77.2M) vs DYN (219M). XFOR has higher revenues than DYN: XFOR (15.8M) vs DYN (0).
DYNXFORDYN / XFOR
Capitalization3.46B359M964%
EBITDA-502.36M-79.76M630%
Gain YTD-5.317-9.50056%
P/E RatioN/A2.53-
Revenue015.8M-
Total Cash898M208M432%
Total Debt219M77.2M284%
FUNDAMENTALS RATINGS
DYN vs XFOR: Fundamental Ratings
DYN
XFOR
OUTLOOK RATING
1..100
5220
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
6263
P/E GROWTH RATING
1..100
10070
SEASONALITY SCORE
1..100
2850

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DYN's Valuation (37) in the Electric Utilities industry is in the same range as XFOR (45) in the Biotechnology industry. This means that DYN’s stock grew similarly to XFOR’s over the last 12 months.

DYN's Profit vs Risk Rating (95) in the Electric Utilities industry is in the same range as XFOR (100) in the Biotechnology industry. This means that DYN’s stock grew similarly to XFOR’s over the last 12 months.

DYN's SMR Rating (98) in the Electric Utilities industry is in the same range as XFOR (99) in the Biotechnology industry. This means that DYN’s stock grew similarly to XFOR’s over the last 12 months.

DYN's Price Growth Rating (62) in the Electric Utilities industry is in the same range as XFOR (63) in the Biotechnology industry. This means that DYN’s stock grew similarly to XFOR’s over the last 12 months.

XFOR's P/E Growth Rating (70) in the Biotechnology industry is in the same range as DYN (100) in the Electric Utilities industry. This means that XFOR’s stock grew similarly to DYN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
DYNXFOR
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
86%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
85%
MACD
ODDS (%)
N/A
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
89%
Advances
ODDS (%)
Bullish Trend 20 days ago
85%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 26 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Sep 15, 2026
Stock price -- (DYN: $18.52 vs. XFOR: $3.62)
Brand notoriety: DYN and XFOR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: DYN: 110% vs. XFOR: 141%
Market capitalization -- DYN: $3.46B vs. XFOR: $358.91M
DYN [@Biotechnology] is valued at $3.46B. XFOR’s [@Biotechnology] market capitalization is $358.91M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $131.68B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

DYN’s FA Score shows that 0 FA rating(s) are green while XFOR’s FA Score has 0 green FA rating(s).

  • DYN’s FA Score: 0 green, 5 red.
  • XFOR’s FA Score: 0 green, 5 red.
According to our system of comparison, both DYN and XFOR are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

DYN’s TA Score shows that 4 TA indicator(s) are bullish while XFOR’s TA Score has 4 bullish TA indicator(s).

  • DYN’s TA Score: 4 bullish, 5 bearish.
  • XFOR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, DYN is a better buy in the short-term than XFOR.

Price Growth

DYN (@Biotechnology) experienced а -23.72% price change this week, while XFOR (@Biotechnology) price change was -10.40% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.85%. For the same industry, the average monthly price growth was -3.79%, and the average quarterly price growth was +6.70%.

Reported Earning Dates

DYN is expected to report earnings on Oct 29, 2026.

XFOR is expected to report earnings on Oct 29, 2026.

Industries' Descriptions

@Biotechnology (-5.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
DYN
Daily Signal:
Gain/Loss:
XFOR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
BGX10.62N/A
N/A
Blackstone Long-Short Credit Income Fund
SJNK24.58-0.02
-0.08%
State Street® SPDR® Blmbg ST HY Bd ETF
USIN47.85-0.04
-0.08%
WisdomTree 7-10 Year Laddered Trsy ETF
WIW8.20-0.02
-0.24%
Western Asset Inflation-Linked Opportunities & Income Fund
EWUS43.59-0.44
-1.01%
iShares MSCI United Kingdom Small-Cp ETF

DYN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DYN has been loosely correlated with RNA. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if DYN jumps, then RNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DYN
1D Price
Change %
DYN100%
+1.70%
RNA - DYN
64%
Loosely correlated
-1.45%
RCKT - DYN
47%
Loosely correlated
+2.39%
BBIO - DYN
46%
Loosely correlated
-0.08%
IDYA - DYN
45%
Loosely correlated
+1.17%
CLDX - DYN
45%
Loosely correlated
+6.18%
More

XFOR and

Correlation & Price change

A.I.dvisor indicates that over the last year, XFOR has been loosely correlated with ABEO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if XFOR jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XFOR
1D Price
Change %
XFOR100%
+3.43%
ABEO - XFOR
35%
Loosely correlated
+0.28%
DYN - XFOR
35%
Loosely correlated
+1.70%
MRVI - XFOR
35%
Loosely correlated
+2.37%
SGMT - XFOR
35%
Loosely correlated
N/A
XCUR - XFOR
34%
Loosely correlated
-2.14%
More